Universal screening to identify socioeconomic needs of children and families affected by sickle cell disease can help to address their…
Articles by Alice Melão
Treatment with voxelotor, Global Blood Therapeutics’ lead therapy candidate, can markedly reduce both hemolysis — the destruction of red blood…
Development of problem-solving skills may help adolescents with sickle cell disease prepare for the transition to adulthood and also improve…
Acute vaso-occlusive pain is associated with the onset of menstruation, and about 25% of the women with sickle…
Global Blood Therapeutics’ lead therapeutic candidate voxelotor can induce rapid, robust, and sustained improvements in the amount of…
Hemolytic transfusion reactions, a serious complication of red blood cell transfusion, can be difficult to diagnose in patients with sickle…
Modus Therapeutics is going to launch a Phase 1 clinical study in the United States to evaluate the potential…
Children with sickle cell disease who experience obstructive sleep apnea (OSA), a breathing disorder during sleep, are at risk…
Once-daily treatment with voxelotor, Global Blood Therapeutics’ lead therapy candidate, can effectively increase the amount of hemoglobin in about 58%…
Negative experiences with a racial connotation are common among adolescents and young adults with sickle cell disease (SCD), Connecticut…